<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2018</study_start_year><condition>(borderline) resectable pancreatic adenocarcinoma</condition><condition>Colorectal liver metastases</condition><condition>Pancreas carcinoma resectable</condition><disease>Pancreas Carcinoma Resectable</disease><disease>(borderline) Resectable Pancreatic Adenocarcinoma</disease><disease>Colorectal Liver Metastases</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2442211</full_dataset_link><location>Netherlands</location><study_start_month>9</study_start_month><keyword>MesoPher</keyword><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Minimally invasive, Indocyanine-Guided Metastasectomy in patients with Colorectal Liver Metastases</name><description>Primary outcome(s): Percentage radical resections
Study Design: N/A: single arm study, Open (masking not used), N/A , unknown, Other</description><dates><creation>2018-09-15</creation></dates><accession>2442211</accession><cross_references><Netherlands National Trial Register>NL7674</Netherlands National Trial Register><EU Clinical Trials Register>2018-003222-92</EU Clinical Trials Register></cross_references></HashMap>